Actively Recruiting
IRIS Registry: Intelligent Research in Sight Registry
Led by American Academy of Ophthalmology · Updated on 2016-07-12
20000000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The IRIS Registry (Intelligent Research in Sight) is the first national eye disease clinical registry in the United States, developed by the American Academy of Ophthalmology. It is designed as a clinical self-improvement tool to help ophthalmologists compare patient outcomes, professional performance, and care processes nationwide. The registry aims to support continuous quality enhancement in eye care practices across the country. This registry collects and analyzes data from ophthalmic ambulatory encounters to promote practice innovations and improve patient care. It allows doctors to monitor patient interactions, track interventions, identify quality gaps, and manage clinical conditions for entire patient populations. Practices can benchmark their results against national data and use the information to optimize care and resource use. Participants contribute data over time, enabling ongoing evaluation of various eye conditions such as glaucoma, macular degeneration, diabetic retinopathy, cataracts, melanoma, and others. The registry measures outcomes like eye exam results, treatment success, patient satisfaction, and preventive care over periods up to five years. This long-term data collection supports continuous quality improvement and benchmarking among ophthalmology practices.
CONDITIONS
Brief Title
IRIS Registry: Intelligent Research in Sight Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who meet the denominator requirements for each measure.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants who undergo routine ophthalmic care are observed over time to track patient interactions, interventions, and clinical outcomes for continuous quality improvement.
Visits occur as part of routine ophthalmology care over several years
Trial Site Locations
Total: 1 location
1
American Academy of Opthalmology
San Francisco, California, United States, 94109
Actively Recruiting
Research Team
A
Andy Khuong
F
Flora Lum, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here